Pseudoachondroplasia is caused through both intra-and extracellular pathogenic pathways

被引:62
作者
Dinser, R
Zaucke, F
Kreppel, F
Hultenby, K
Kochanek, S
Paulsson, M
Maurer, P
机构
[1] Univ Cologne, Inst Biochem 2, Cologne, Germany
[2] Univ Cologne, Fac Med, Ctr Mol Med, Cologne, Germany
[3] Huddinge Univ Hosp, Karolinska Inst, Clin Res Ctr, Stockholm, Sweden
关键词
D O I
10.1172/JCI200214386
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Pseudoachondroplasia is a dominantly inherited chondrodysplasia associated with mutations in cartilage oligomeric matrix protein (COMP). Investigations into the pathogenesis of pseudoachondroplasia are hampered by its rarity. We developed a cell culture model by expressing mutant COMP in bovine primary chondrocytes using a gutless adenoviral vector. We show that mutant COMP exerts its deleterious effects through both intra- and extracellular pathogenic pathways. Overexpression of mutant COMP led to a dose-dependent decrease in cellular viability. The secretion of mutant COMP was markedly delayed, presumably due to a prolonged association with chaperones in the endoplasmic reticulum (ER). The ECM lacked organized collagen fibers and showed amorphous aggregates formed by mutant COMP. Thus, pseudoachondroplasia appears to be an ER storage disease, most likely caused by improper folding of mutant COMP. The growth failure of affected patients may be explained by an increased cell death of growth-plate chondrocytes. Dominant interference of the mutant protein on collagen fiber assembly could contribute to the observed failure of the ECM of cartilage and tendons.
引用
收藏
页码:505 / 513
页数:9
相关论文
共 46 条
[11]  
HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
[12]   Characterization of cartilage oligomeric matrix protein (COMP) in human normal and pseudoachondroplasia musculoskeletal tissues [J].
Hecht, JT ;
Deere, M ;
Putnam, E ;
Cole, W ;
Vertel, B ;
Chen, H ;
Lawler, J .
MATRIX BIOLOGY, 1998, 17 (04) :269-278
[13]   Retention of cartilage oligomeric matrix protein (COMP) and cell death in redifferentiated pseudoachandroplasia chondrocytes [J].
Hecht, JT ;
Montufar-Solis, D ;
Decker, G ;
Lawler, J ;
Daniels, K ;
Duke, PJ .
MATRIX BIOLOGY, 1998, 17 (8-9) :625-633
[14]   MUTATIONS IN EXON 17B OF CARTILAGE OLIGOMERIC MATRIX PROTEIN (COMP) CAUSE PSEUDOACHONDROPLASIA [J].
HECHT, JT ;
NELSON, LD ;
CROWDER, E ;
WANG, Y ;
ELDER, FFB ;
HARRISON, WR ;
FRANCOMANO, CA ;
PRANGE, CK ;
LENNON, GG ;
DEERE, M ;
LAWLER, J .
NATURE GENETICS, 1995, 10 (03) :325-329
[15]   Cartilage oligomeric matrix protein interacts with type IX collagen, and disruptions to these interactions identify a pathogenetic mechanism in a bone dysplasia family [J].
Holden, P ;
Meadows, RS ;
Chapman, KL ;
Grant, ME ;
Kadler, KE ;
Briggs, MD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (08) :6046-6055
[16]  
HULTENBY K, 1993, EUR J CELL BIOL, V62, P86
[17]   Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: Disorders of protein trafficking and the role of ER molecular chaperones [J].
Kim, PS ;
Arvan, P .
ENDOCRINE REVIEWS, 1998, 19 (02) :173-202
[18]   Molecular structure, processing, and tissue distribution of matrilin-4 [J].
Klatt, AR ;
Nitsche, DP ;
Kobbe, B ;
Macht, M ;
Paulsson, M ;
Wagener, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (20) :17267-17275
[19]   High-capacity adenoviral vectors for gene transfer and somatic gene therapy [J].
Kochanek, S .
HUMAN GENE THERAPY, 1999, 10 (15) :2451-2459
[20]   A DNA-based method to assay total and infectious particle contents and helper virus contamination in high-capacity adenoviral vector preparations [J].
Kreppel, F ;
Biermann, V ;
Kochanek, S ;
Schiedner, G .
HUMAN GENE THERAPY, 2002, 13 (10) :1151-1156